Literature DB >> 27112458

Vasopressor therapy: not like antibiotics!

Jan Bakker1,2,3, Jukka Takala4.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27112458     DOI： 10.1007/s00134-016-4335-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Normalizing physiological variables in acute illness: five reasons for caution.

Authors:  Brian P Kavanagh; L Joanne Meyer
Journal:  Intensive Care Med       Date:  2005-07-26       Impact factor: 17.440

2.  Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure.

Authors:  O Abid; S Akça; P Haji-Michael; J L Vincent
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

3.  Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial.

Authors:  François Lamontagne; Maureen O Meade; Paul C Hébert; Pierre Asfar; François Lauzier; Andrew J E Seely; Andrew G Day; Sangeeta Mehta; John Muscedere; Sean M Bagshaw; Niall D Ferguson; Deborah J Cook; Salmaan Kanji; Alexis F Turgeon; Margaret S Herridge; Sanjay Subramanian; Jacques Lacroix; Neill K J Adhikari; Damon C Scales; Alison Fox-Robichaud; Yoanna Skrobik; Richard P Whitlock; Robert S Green; Karen K Y Koo; Teddie Tanguay; Sheldon Magder; Daren K Heyland
Journal:  Intensive Care Med       Date:  2016-02-18       Impact factor: 17.440

4.  Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock.

Authors:  G Bernardin; C Pradier; F Tiger; P Deloffre; M Mattei
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

Review 5.  Re-thinking resuscitation: leaving blood pressure cosmetics behind and moving forward to permissive hypotension and a tissue perfusion-based approach.

Authors:  Martin W Dünser; Jukka Takala; Andreas Brunauer; Jan Bakker
Journal:  Crit Care       Date:  2013-10-08       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.